The single-dose vials are priced at a 50% or greater discount compared to the list price of all other incretin (GLP-1) medicines for obesity
Cell 138: 628644 ChacinskaA,PfannschmidtS,WiedemannN,KozjakV,Sanjuan SzklarzLK,SchulzeSpeckingA,TruscottKN,GuiardB,MeisingerC,PfannerN (2004) Essential role of Mia40 in import and assembly of mitochondrial intermembrane space proteins
Exposure to Radiation: Radiation from medical imaging (like X-rays and CT scans) or environmental sources (such as UV rays from the sun) generates free radicals
Strongest human evidence The METAOD006 (OPTIONS) Phase 2b trial randomized 502 adults with obesity (BMI 30-45 kg/m^2) to oral AOD-9604 (0.25, 0.5, or 1 mg/day) or placebo for 24 weeks alongside a supervised diet and exercise program
For example, persistent gastrointestinal symptoms leading to dehydration or a noticeable drop in eGFR or increase in UACR should prompt a temporary pause in medication